NEW YORK (GenomeWeb News) – The External RNA Controls Consortium today said that eight testing sites have registered for the initial phase of the RNA control testing initiative.
 
The participants are: Affymetrix, Agilent, Applied Biosystems, GE Healthcare, Illumina, National Institute of Allergy and Infectious Diseases, Qiagen, and Roche Molecular Systems.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.